Telemonitoring and self-management in the control of hypertension (TASMINH2): A cost-effectiveness analysis

European Journal of Preventive Cardiology

Volumn 21, Issue 12, 2014, Pages 1517-1530

  Kaambwa, Billingsley ^a   Bryan, Stirling ^b   Jowett, Sue ^c   Mant, Jonathan ^d   Bray, Emma P ^c   Hobbs, F D Richard ^e   Holder, Roger ^c   Jones, Miren I ^c   Little, Paul ^f   Williams, Bryan ^g   McManus, Richard J ^e  

^a FLINDERS UNIVERSITY   (Australia)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^d UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^e UNIVERSITY OF OXFORD   (United Kingdom)

^f UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^g UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

cost effectiveness; Hypertension; self management; telemonitoring

Indexed keywords

ANTIHYPERTENSIVE AGENT;

AGED; ANGINA PECTORIS; ARTICLE; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; FEMALE; HEALTH CARE COST; HEALTH SERVICE; HEART FAILURE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; QUALITY ADJUSTED LIFE YEAR; RANDOMIZED CONTROLLED TRIAL; SELF CARE; SELF CONCEPT; TELEMONITORING; UNITED KINGDOM; VERY ELDERLY; ADULT; BLOOD PRESSURE; CLINICAL TRIAL; COST BENEFIT ANALYSIS; DRUG COST; DRUG EFFECTS; ECONOMICS; MIDDLE AGED; MULTICENTER STUDY; PATHOPHYSIOLOGY; PROBABILITY; PROCEDURES; PROSPECTIVE STUDY; QUALITY OF LIFE; STATISTICAL MODEL; TELEMEDICINE; TIME; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; COST-BENEFIT ANALYSIS; DRUG COSTS; FEMALE; GREAT BRITAIN; HEALTH CARE COSTS; HUMANS; HYPERTENSION; MALE; MARKOV CHAINS; MIDDLE AGED; MODELS, ECONOMIC; PROSPECTIVE STUDIES; QUALITY OF LIFE; QUALITY-ADJUSTED LIFE YEARS; SELF CARE; TELEMEDICINE; TIME FACTORS; TREATMENT OUTCOME;

EID: 84911940262     PISSN: 20474873     EISSN: 20474881     Source Type: Journal    
DOI: 10.1177/2047487313501886     Document Type: Article

References (51)

1. Health survey for England 2006. London: HMSO ; 2006 :
2. NHS Information Centre. Quality and Outcomes Framework 2008/09. Online GP practice results database. http://www.hscic.gov.uk/qof (2009, accessed 11 March 2012).
3. Allen N, Berry JD, Ning H, et al. Impact of blood pressure and blood pressure change during middle age on the remaining lifetime risk for cardiovascular disease: The cardiovascular lifetime risk pooling project. Circulation. 2012 ; 125: 37-44
4. Law MR, Morris JK, Wald NJ. Use of blood pressure lowering drugs in the prevention of cardiovascular disease: Meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies. BMJ. 2009 ; 338: b1665 - b1665
5. Dickinson HO, Mason JM, Nicolson DJ, et al. Lifestyle interventions to reduce raised blood pressure: A systematic review of randomized controlled trials. J Hypertens. 2006 ; 24: 215-233
6. McAndrew L, Schneider SH, Burns E, et al. Does patient blood glucose monitoring improve diabetes control? A systematic review of the literature. Diabetes Educ. 2007 ; 33: 991-1011
7. Levi M. Self-management of anticoagulation. Expert Rev Cardiovasc Ther. 2008 ; 6: 979-985
8. McManus RJ, Mant J, Bray EP, et al. Telemonitoring and self-management in the control of hypertension (TASMINH2): A randomised controlled trial. Lancet. 2010 ; 376: 163-172
9. Soghikian K, Casper SM, Fireman BH, et al. Home blood pressure monitoring. Effect on use of medical services and medical care costs. Med Care. 1992 ; 30: 855-865
10. Reed SD, Li Y, Oddone EZ, et al. Economic evaluation of home blood pressure monitoring with or without telephonic behavioral self-management in patients with hypertension. Am J Hypertens. 2010 ; 23: 142-148
11. McManus RJ, Mant J, Roalfe A, et al. Targets and self monitoring in hypertension: Randomised controlled trial and cost effectiveness analysis. BMJ. 2005 ; 331: 493-493
12. Fukunaga H, Ohkubo T, Kobayashi M, et al. Cost-effectiveness of the introduction of home blood pressure measurement in patients with office hypertension. J Hypertens. 2008 ; 26: 685-690
13. Madsen LB, Christiansen T, Kirkegaard P, et al. Economic evaluation of home blood pressure telemonitoring: A randomized controlled trial. Blood Press. 2011 ; 20: 117-125
14. Chapman RH, Kowal SL, Cherry SB, et al. The modeled lifetime cost-effectiveness of published adherence-improving interventions for antihypertensive and lipid-lowering medications. Value Health. 2010 ; 13: 685-694
15. Richardson G, Sculpher M, Kennedy A, et al. Is self-care a cost-effective use of resources? Evidence from a randomized trial in inflammatory bowel disease. J Health Serv Res Policy. 2006 ; 11: 225-230
16. McManus RJ, Bray EP, Mant J, et al. Protocol for a randomised controlled trial of telemonitoring and self-management in the control of hypertension: Telemonitoring and self-management in hypertension. [ISRCTN17585681]. BMC Cardiovasc Disord. 2009 ; 9: 6-6
17. McManus RJ, Ryan R, Jones M, et al. How representative of primary care are research active practices? Cross-sectional survey. Fam Pract. 2008 ; 25: 56-62
18. British Medical Association. British Medical Association and NHS Employers. Quality and Outcomes Framework guidance. 3rd revision. London: BMA, 2009.
19. National Institute for Clinical Excellence. CG34 Hypertension (persistently high blood pressure) in adults - NICE guideline. http://www.nice.org.uk/nicemedia/pdf/CG34publicinfo.pdf (2006, accessed 24 February 2012).
20. TreeAge Pro 2009 Suite. Williamstown, MA.: TreeAge Software, Inc. ; 2009 :
21. Sonnenberg FA, Beck JR. Markov models in medical decision making: A practical guide. Med Decis Making. 1993 ; 13: 322-338
22. Beck JR, Pauker SG. The Markov process in medical prognosis. Med Decis Making. 1983 ; 3: 419-458
23. D'Agostino RB, Vasan RS, Pencina MJ, et al. General cardiovascular risk profile for use in primary care: The Framingham Heart Study. Circulation. 2008 ; 117: 743-753
24. Unstable angina and NSTEMI: The early management of unstable angina and non-ST-segment-elevation myocardial infarction. (CG94). London: Royal College of Physicians ; 2010 :
25. De Giuli F, Khaw KT, Cowie MR, et al. Incidence and outcome of persons with a clinical diagnosis of heart failure in a general practice population of 696,884 in the United Kingdom. Eur J Heart Fail. 2005 ; 7: 295-302
26. Bronnum-Hansen H, Jorgensen T, Davidsen M, et al. Survival and cause of death after myocardial infarction: The Danish MONICA study. J Clin Epidemiol. 2001 ; 54: 1244-1250
27. Leng GC, Lee AJ, Fowkes FG, et al. Incidence, natural history and cardiovascular events in symptomatic and asymptomatic peripheral arterial disease in the general population. Int J Epidemiol. 1996 ; 25: 1172-1181
28. Mehta PA, Dubrey SW, McIntyre HF, et al. Improving survival in the 6 months after diagnosis of heart failure in the past decade: Population-based data from the UK. Heart. 2009 ; 95: 1851-1856
29. Volmink JA, Newton JN, Hicks NR, et al. Coronary event and case fatality rates in an English population: Results of the Oxford myocardial infarction incidence study. The Oxford Myocardial Infarction Incidence Study Group. Heart. 1998 ; 80: 40-44
30. Bamford J, Sandercock P, Dennis M, et al. A prospective study of acute cerebrovascular disease in the community: The Oxfordshire Community Stroke Project - 1981-86. 2. Incidence, case fatality rates and overall outcome at one year of cerebral infarction, primary intracerebral and subarachnoid haemorrhage. J Neurol Neurosurg Psychiatry. 1990 ; 53: 16-22
31. Anderson KM, Odell PM, Wilson PW, et al. Cardiovascular disease risk profiles. Am Heart J. 1991 ; 121: 293-298
32. Wood D, Kotseva K, Fox K, et al Health care needs assessment: The epidemiologically based needs assessment reviews. 2 nd ed. Abingdon, UK: Radcliffe Medical Press Ltd, 2004, pp. 373-448. Stevens A Raftery J Mant J, ed. Abingdon, UK: Radcliffe Medical Press Ltd ; 2004: 373-448.
33. Guide to the methods of technology appraisal. London: NICE ; 2004 :
34. Drummond MF, Sculpher MJ, O'Brien B, et al Methods for the economic evaluation of health care programmes. Oxford: Oxford University Press ; 2005 :
35. Department of Health. NHS reference costs 2008-2009. http://www.dh.gov.uk/en/Publicationsandstatistics/Publications/PublicationsPolicyAndGuidance/DH-111591 (2010, accessed 3 March 2012).
36. Palmer S, Sculpher M, Philips Z, et al A cost effectiveness model comparing alternative management strategies for the use of glycoprotein iiB/iiiA antagonists in non-ST-elevation acute coronary syndrome. York, UK: Centre for Health Economics ; 2004 :
37. Youman P, Wilson K, Harraf F, et al. The economic burden of stroke in the United Kingdom. Pharmacoeconomics. 2003 ; 21: 43-50
38. Cooper A, Nherera L, Calvert N, et al Clinical guidelines and evidence review for lipid modification: Cardiovascular risk assessment and the primary and secondary prevention of cardiovascular disease. London: National Collaborating Centre for Primary Care and Royal College of General Practitioners ; 2008 :
39. Kind P, Hardman G and Macran S. UK population norms for EQ-5D: Discussion paper 172. York, UK: Centre for Health Economics, 1999.
40. Black WC. The CE plane: A graphic representation of cost-effectiveness. Med Decis Making. 1990 ; 10: 212-214
41. Briggs AH, Gray AM. Handling uncertainty when performing economic evaluation of healthcare interventions. Health Technol Assess. 1999 ; 3: 1-134
42. Department of Health. NHS reference costs 2007-08. http://www.dh.gov.uk/en/Publicationsandstatistics/Publications/PublicationsPolicyAndGuidance/DH-098945 (2009, accessed 28 February 2012).
43. Effects on 11-year mortality and morbidity of lowering LDL cholesterol with simvastatin for about 5 years in 20,536 high-risk individuals: A randomised controlled trial. Lancet. 2011 ; 378: 2013-2020
44. Bosworth HB, Olsen MK, Grubber JM, et al. Two self-management interventions to improve hypertension control: A randomized trial. Ann Intern Med. 2009 ; 151: 687-695
45. Rodondi N, Locatelli I, Aujesky D, et al. for the Health ABC Study. Framingham Risk Score and Alternatives for Prediction of Coronary Heart Disease in Older Adults. PLoS One 2012; 7: e34287.
46. Jowett S, Bryan S, Murray E, et al. Patient self-management of anticoagulation therapy: A trial-based cost-effectiveness analysis. Br J Haematol. 2006 ; 134: 632-639
47. Lahdensuo A, Haahtela T, Herrala J, et al. Randomised comparison of cost effectiveness of guided self management and traditional treatment of asthma in Finland. BMJ. 1998 ; 316: 1138-1139
48. Global health risks: Mortality and burden of disease attributable to selected major risks. Geneva: WHO Press ; 2009 :
49. Gomez-Marcos MA, Gonzalez-Elena LJ, Recio-Rodriguez JI, et al. Cardiovascular risk assessment in hypertensive patients with tests recommended by the European Guidelines on Hypertension. EJPC. 2012 ; 19: 515-522
50. Godet-Mardirossian H, Girerd X, Vernay M, et al. Patterns of hypertension management in France (ENNS 2006-2007). EJPC. 2012 ; 19: 213-220
51. Briggs A, Claxton K, Sculpher M Decision modelling for health economic evaluation. Oxford: Oxford University Press ; 2006 :